1990
DOI: 10.1016/0006-8993(90)90028-a
|View full text |Cite
|
Sign up to set email alerts
|

Effect of adrenergic agonists on glycogenolysis in primary cultures of astrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
84
0
1

Year Published

1993
1993
2019
2019

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 120 publications
(90 citation statements)
references
References 33 publications
5
84
0
1
Order By: Relevance
“…Furthermore, as shown in Fig. 5, the neuropro tective effects of both agents can be abolished by brief exposure to NE or dB cAMP , sufficient to de plete glycogen back down to near control levels by induction of rapid glycogenolysis (Opler and Mak man, 1972;Subbarao and Hertz, 1990). Exposure to NE and dBcAMP without prior treatment with in sulin or MSO caused little or no increase in neuro nal vulnerability to glucose deprivation.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…Furthermore, as shown in Fig. 5, the neuropro tective effects of both agents can be abolished by brief exposure to NE or dB cAMP , sufficient to de plete glycogen back down to near control levels by induction of rapid glycogenolysis (Opler and Mak man, 1972;Subbarao and Hertz, 1990). Exposure to NE and dBcAMP without prior treatment with in sulin or MSO caused little or no increase in neuro nal vulnerability to glucose deprivation.…”
Section: Discussionmentioning
confidence: 91%
“…The cultures were used for biochemical determinations or glucose depriva tion experiments after 24 h incubation. Some of these cultures were also exposed to 20 j-lM norepinephrine (NE) or 1 mM dibutyryl cAMP (dBcAMP), agents known to decrease glial glycogen content (Opler and Makman, 1972;Subbarao and Hertz, 1990), for 30 min immediately before use. All reagents were added from 50x or 100x stock solutions prepared in water, except insulin which was stored at 1 ,000 x (1 mM) in 0.1% albumin.…”
Section: Manipulation Of Glycogen Levelsmentioning
confidence: 99%
“…As noradrenaline promotes glycogenolysis (Magistretti, 1988;Subbarao and Hertz, 1990;Sorg and Magistretti, 1991;Coopersmith and Leon, 1995), the action of b-AR agonists b-ARs in central metabolism and memory ME Gibbs et al was challenged with the glycogen phosphorylase inhibitor DAB that prevents glycogen breakdown (Andersen et al, 1999;Andersen and Westergaard, 2002). We have shown that administration of DAB interferes with memory processing (Gibbs et al, 2006a).…”
Section: -Ar Agonists Affect Memory Formation By Activating Glycogenomentioning
confidence: 87%
“…In contrast, none of these metabolic inhibitors affected the ability of the b 2 -AR agonist zinterol to consolidate weakly reinforced memory. This effect was counteracted by DAB, suggesting that zinterol acts by stimulating glycogenolysis (Nahorski et al, 1975;Magistretti, 1988;Subbarao and Hertz, 1990;Coopersmith and Leon, 1995). There was no interaction between CL316243 and DAB.…”
Section: Interactions Between B 2 -And B 3 -Ars and Glucose Metabolismmentioning
confidence: 94%
“…This mode of activation is less rapid than that evoked by K + (Subbarao and Hertz, 1990) and is executed via specific subclasses of receptors and second messenger systems. For example, noradrenaline increases glycogen phosphorylase activity via protein kinase A activation in response to b-adrenergic receptor stimulation and by an increase in [Ca 2 + ] i in a 2 -adrenergic receptor stimulation.…”
Section: Fuel For Regulation Of Extracellular K + Concentration By Asmentioning
confidence: 97%